Brinksma, Djûke M.
Hoekstra, Pieter J.
de Bildt, Annelies
Buitelaar, Jan K.
van den Hoofdakker, Barbara J.
Hartman, Catharina A.
Dietrich, Andrea http://orcid.org/0000-0002-2538-6136
Article History
Received: 11 August 2020
Accepted: 7 July 2021
First Online: 17 July 2021
Declarations
:
: Jan K. Buitelaar has been a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Takeda/Shire, Roche, Medice, Novartis, and Servier. He has received research support from Roche and Vifor. He is not an employee or a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, and royalties. Pieter Hoekstra has been a member of an advisory board meeting of Takeda/Shire. The other authors have no conflicts of interest.
: The TRAILS study was approved by the Central Committee on Research Involving Human Subjects (Dutch CCMO).
: All parents and children > 12 years provided written informed consent to participate.
: All authors have approved the manuscript and have provided consent for publication.